Clinical Trial Update: Effects of the GLP-1 Exenatide on Satiety in Lean and Obese Women [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial assessing the effect of the GLP-1 agonist exenatide on satiety in lean and obese women has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• EXENATIDE (EXENATIDE)

Snippet

Sponsor: University of California, Los Angeles | Conditions: Obesity | Phase 1 | Status: COMPLETED